WCM
TMO icon

Wedge Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Wedge Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$406K Sell
809
-11,212
-93% -$5.38M 0.01% 445
2026
Q1 		$5.91M Sell
12,021
-204
-2% -$111K 0.11% 188
2025
Q4 		$7.08M Sell
12,225
-6,634
-35% -$3.75M 0.13% 174
2025
Q3 		$9.15M Buy
18,859
+1,012
+6% +$471K 0.15% 163
2025
Q2 		$7.24M Buy
17,847
+10,381
+139% +$4.34M 0.13% 169
2025
Q1 		$3.72M Buy
7,466
+6,760
+958% +$3.66M 0.07% 227
2024
Q4 		$367K Buy
706
+28
+4% +$15.4K 0.01% 481
2024
Q3 		$419K Buy
678
+14
+2% +$8.29K 0.01% 469
2024
Q2 		$367K Sell
664
-78
-11% -$44.7K 0.01% 460
2024
Q1 		$431K Buy
742
+7
+1% +$3.93K 0.01% 460
2023
Q4 		$390K Sell
735
-5
-0.7% -$2.42K 0.01% 453
2023
Q3 		$375K Buy
740
+57
+8% +$30.4K 0.01% 453
2023
Q2 		$356K Sell
683
-17
-2% -$9.17K 0.01% 483
2023
Q1 		$403K Sell
700
-3
-0.4% -$1.69K 0.01% 330
2022
Q4 		$387K Buy
703
+9
+1% +$4.77K 0.01% 329
2022
Q3 		$352K Sell
694
-22
-3% -$12.3K 0.01% 330
2022
Q2 		$389K Hold
716
– – 0.01% 327
2022
Q1 		$423K Sell
716
-17
-2% -$9.77K 0.01% 323
2021
Q4 		$489K Buy
733
+15
+2% +$9.37K 0.01% 321
2021
Q3 		$410K Sell
718
-20
-3% -$11K 0.01% 326
2021
Q2 		$372K Sell
738
-167
-18% -$78.8K ﹤0.01% 325
2021
Q1 		$413K Sell
905
-37
-4% -$17.7K ﹤0.01% 389
2020
Q4 		$439K Hold
942
– – 0.01% 415
2020
Q3 		$416K Buy
942
+26
+3% +$10.7K 0.01% 399
2020
Q2 		$332K Sell
916
-37
-4% -$12.4K ﹤0.01% 406
2020
Q1 		$270K Buy
953
+13
+1% +$4.1K ﹤0.01% 419
2019
Q4 		$305K Buy
940
+16
+2% +$4.85K ﹤0.01% 472
2019
Q3 		$269K Sell
924
-11
-1% -$3.15K ﹤0.01% 496
2019
Q2 		$275K Buy
+935
New +$258K ﹤0.01% 542

Other funds holding TMO

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Wedge Capital Management's TMO Position: Q2 2026 in Review

Wedge Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 93% in Q2 2026, selling an estimated $5.38M and leaving 809 shares worth $406K. The position accounts for 0.01% of the portfolio, ranked #445.

Wedge Capital Management first reported a position in TMO in Q2 2019 and has held it in 29 quarters since. The position peaked at $9.15M in Q3 2025. 794 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Wedge Capital Management held 809 shares of Thermo Fisher Scientific worth $406K as of Q2 2026.
  • Wedge Capital Management sold 11,212 Thermo Fisher Scientific shares in Q2 2026, an estimated $5.38M.
  • Thermo Fisher Scientific made up 0.01% of Wedge Capital Management's portfolio in Q2 2026, its #445 holding.
  • Wedge Capital Management first reported a position in Thermo Fisher Scientific in Q2 2019 and has held it in 29 quarters since.
  • Wedge Capital Management's Thermo Fisher Scientific position peaked at $9.15M in Q3 2025.
  • 794 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Wedge Capital Management's 13F filing for Q2 2026, filed 10 Jul 2026.